Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia
Joint Authors
James, Suneeta
Kapugama, Chaya
Al-Uzri, Mohammed
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-02-15
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Background.
Evidence for the efficacious use of second-generation antipsychotics for the treatment of negative symptoms in schizophrenia is scant.
Case Presentation.
We report the case of a 34-year-old female of Afro-Caribbean origin, who presented with prominent negative symptoms of schizophrenia and was successfully treated with aripiprazole long acting injection.
Within a period of six to nine months, the patient returned to her premorbid level of functioning.
Conclusion.
Aripiprazole long acting injection promises benefits in the treatment of negative symptoms of schizophrenia.
Further research needs to be conducted on the use of this drug.
American Psychological Association (APA)
James, Suneeta& Kapugama, Chaya& Al-Uzri, Mohammed. 2016. Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia. Case Reports in Psychiatry،Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1102511
Modern Language Association (MLA)
James, Suneeta…[et al.]. Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia. Case Reports in Psychiatry No. 2016 (2016), pp.1-3.
https://search.emarefa.net/detail/BIM-1102511
American Medical Association (AMA)
James, Suneeta& Kapugama, Chaya& Al-Uzri, Mohammed. Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia. Case Reports in Psychiatry. 2016. Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1102511
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1102511